{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:24Z","timestamp":1794047364813,"version":"4.8.0"},"reference-count":57,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Congenital amegakaryocytic thrombocytopenia caused by deleterious homozygous or compound heterozygous mutations in MPL (CAMT-MPL) is a rare inherited bone marrow failure syndrome presenting as an isolated thrombocytopenia at birth progressing to pancytopenia due to exhaustion of hematopoietic progenitors. The analysis of samples and clinical data from a large cohort of 56 patients with CAMT-MPL resulted in a detailed description of the clinical picture and reliable genotype-phenotype correlations for this rare disease. We extended the spectrum of CAMT causing MPL mutations regarding number (17 novel mutations) and impact. The clinical courses showed a great variability with respect to the severity of thrombocytopenia, the development of pancytopenia and the consequences from bleedings. The most severe clinical problems were (1) intracranial bleedings pre- and perinatally and the resulting long-term consequences, and (2) the development of aplastic anemia in the later course of the disease. An important and new finding was that thrombocytopenia was not detected at birth in a quarter of the patients. The rate of non-hematological abnormalities in CAMT-MPL was higher than described so far. Most of the anomalies were related to the head region (brain anomalies, ocular and orbital anomalies) and consequences of intracranial bleedings. The present study demonstrates a higher variability of clinical courses than described so far and has important implications on diagnosis and therapy. The diagnosis CAMT-MPL has to be considered even for those patients who are inconspicuous in the first months of life or show somatic anomalies typical for other inherited bone marrow failure syndromes.<\/jats:p>","DOI":"10.3324\/haematol.2020.257972","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:02:48Z","timestamp":1595498568000},"page":"2439-2448","source":"Crossref","is-referenced-by-count":45,"title":["CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients"],"prefix":"10.3324","volume":"106","author":[{"family":"Manuela Germeshausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Matthias Ballmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"29063","doi-asserted-by":"crossref","unstructured":"Ballmaier M, Germeshausen M.. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol. 2009; 146(1):3-16.","DOI":"10.1111\/j.1365-2141.2009.07706.x"},{"key":"29064","doi-asserted-by":"crossref","unstructured":"Ballmaier M, Germeshausen M.. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011; 37(6):673-681.","DOI":"10.1055\/s-0031-1291377"},{"key":"29065","doi-asserted-by":"crossref","unstructured":"Ihara K, Ishii E, Eguchi M. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A. 1999; 96(6):3132-3136.","DOI":"10.1073\/pnas.96.6.3132"},{"key":"29066","doi-asserted-by":"crossref","unstructured":"Ballmaier M, Germeshausen M, Schulze H. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1):139-146.","DOI":"10.1182\/blood.V97.1.139"},{"key":"29067","doi-asserted-by":"crossref","unstructured":"Dokal I, Vulliamy T.. Inherited bone marrow failure syndromes. Haematologica. 2010; 95(8):1236-1240.","DOI":"10.3324\/haematol.2010.025619"},{"key":"29068","doi-asserted-by":"crossref","unstructured":"Dasouki MJ, Rafi SK, Olm-Shipman AJ. Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia. Blood. 2013; 122(20):3440-3449.","DOI":"10.1182\/blood-2012-12-473538"},{"key":"29069","doi-asserted-by":"crossref","unstructured":"Seo A, Ben-Harosh M, Sirin M. Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin. Blood. 2017; 130(7):875-880.","DOI":"10.1182\/blood-2017-02-768036"},{"key":"29070","doi-asserted-by":"crossref","unstructured":"Pecci A, Ragab I, Bozzi V. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim. EMBO Mol Med. 2018; 10(1):63-75.","DOI":"10.15252\/emmm.201708168"},{"key":"29071","doi-asserted-by":"crossref","unstructured":"Basel-Vanagaite L, Dokal I, Tamary H. Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations. Haematologica. 2008; 93(6):943-944.","DOI":"10.3324\/haematol.12317"},{"key":"29072","doi-asserted-by":"crossref","unstructured":"Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: an international Fanconi Anemia Registry Study. Am J Med Genet. 1997; 68(1):58-61.","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<58::AID-AJMG11>3.0.CO;2-N"},{"key":"29073","doi-asserted-by":"crossref","unstructured":"Germeshausen M, Ancliff P, Estrada J. MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood Adv. 2018; 2(6):586-596.","DOI":"10.1182\/bloodadvances.2018016501"},{"key":"29074","doi-asserted-by":"crossref","unstructured":"Christensen RD, Wiedmeier SE, Yaish HM. A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at 21q22.11 including the gene RUNX1. J Perinatol. 2013; 33(3):242-244.","DOI":"10.1038\/jp.2012.53"},{"key":"29075","doi-asserted-by":"crossref","unstructured":"Geddis AE. Congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer. 2011; 57(2):199-203.","DOI":"10.1002\/pbc.22927"},{"key":"29076","doi-asserted-by":"crossref","unstructured":"King S, Germeshausen M, Strauss G, Welte K, Ballmaier M.. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005; 131(5):636-644.","DOI":"10.1111\/j.1365-2141.2005.05819.x"},{"key":"29077","doi-asserted-by":"crossref","unstructured":"Germeshausen M, Ballmaier M, Welte K.. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006; 27(3):296.","DOI":"10.1002\/humu.9415"},{"key":"29078","doi-asserted-by":"crossref","unstructured":"Stoddart MT, Connor P, Germeshausen M, Ballmaier M, Steward CG. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life. Pediatr Blood Cancer. 2013; 60(9):E94-96.","DOI":"10.1002\/pbc.24566"},{"key":"29079","doi-asserted-by":"crossref","unstructured":"Ok Bozkaya I, Yarali N, Isik P, Unsal Sac R, Tavil B, Tunc B.. Severe clinical course in a patient with congenital amegakaryocytic thrombocytopenia due to a missense mutation of the c-MPL gene. Turk J Haematol. 2015; 32(2):172-174.","DOI":"10.4274\/Tjh.2013.0191"},{"key":"29080","doi-asserted-by":"crossref","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015; 31(16):2745-2747.","DOI":"10.1093\/bioinformatics\/btv195"},{"key":"29081","doi-asserted-by":"crossref","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4(7):1073-1081.","DOI":"10.1038\/nprot.2009.86"},{"key":"29082","doi-asserted-by":"crossref","unstructured":"Adzhubei IA, Schmidt S, Peshkin L. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-249.","DOI":"10.1038\/nmeth0410-248"},{"key":"29083","doi-asserted-by":"crossref","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D.. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11(4):361-362.","DOI":"10.1038\/nmeth.2890"},{"key":"29084","doi-asserted-by":"crossref","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D.. Improved splice site detection in Genie. J Comput Biol. 1997; 4(3):311-323.","DOI":"10.1089\/cmb.1997.4.311"},{"key":"29085","doi-asserted-by":"crossref","unstructured":"Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004; 11(2-3):377-394.","DOI":"10.1089\/1066527041410418"},{"key":"29086","doi-asserted-by":"crossref","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C.. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009; 37(9):e67.","DOI":"10.1093\/nar\/gkp215"},{"key":"29087","doi-asserted-by":"crossref","unstructured":"Ballmaier M, Holter W, Germeshausen M.. Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias. Haematologica. 2015; 100(9):e341-344.","DOI":"10.3324\/haematol.2015.125963"},{"key":"29088","doi-asserted-by":"crossref","unstructured":"Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG. Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation. Exp Hematol. 2005; 33(10):1215-1221.","DOI":"10.1016\/j.exphem.2005.06.017"},{"key":"29089","doi-asserted-by":"crossref","unstructured":"Varghese LN, Zhang JG, Young SN. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia. Growth Factors. 2014; 32(1):18-26.","DOI":"10.3109\/08977194.2013.874347"},{"key":"29090","doi-asserted-by":"crossref","unstructured":"Jalas C, Anderson SL, Laufer T. A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population. Blood Cells Mol Dis. 2011; 47(1):79-83.","DOI":"10.1016\/j.bcmd.2011.03.006"},{"key":"29091","doi-asserted-by":"crossref","unstructured":"Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2007; 2007:29-39.","DOI":"10.1182\/asheducation-2007.1.29"},{"key":"29092","doi-asserted-by":"crossref","unstructured":"Steele M, Hitzler J, Doyle JJ. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7. Pediatr Blood Cancer. 2005; 45(2):212-216.","DOI":"10.1002\/pbc.20332"},{"key":"29093","doi-asserted-by":"crossref","unstructured":"Tuller T, Waldman YY, Kupiec M, Ruppin E.. Translation efficiency is determined by both codon bias and folding energy. Proc Natl Acad Sci U S A. 2010; 107(8):3645-3650.","DOI":"10.1073\/pnas.0909910107"},{"key":"29094","doi-asserted-by":"crossref","unstructured":"Dokal I, Vulliamy T.. Inherited aplastic anaemias\/bone marrow failure syndromes. Blood Rev. 2008; 22(3):141-153.","DOI":"10.1016\/j.blre.2007.11.003"},{"key":"29095","doi-asserted-by":"crossref","unstructured":"Weinzierl EP, Arber DA. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2013; 139(1):9-29.","DOI":"10.1309\/AJCP50AEEYGREWUZ"},{"key":"29096","doi-asserted-by":"crossref","unstructured":"Rivers A, Slayton WB. Congenital cytopenias and bone marrow failure syndromes. Semin Perinatol. 2009; 33(1):20-28.","DOI":"10.1053\/j.semperi.2008.10.009"},{"key":"29097","doi-asserted-by":"crossref","unstructured":"Geddis AE. Inherited thrombocytopenia: Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Semin Hematol. 2006; 43(3):196-203.","DOI":"10.1053\/j.seminhematol.2006.04.003"},{"key":"29098","doi-asserted-by":"crossref","unstructured":"Sola-Visner M. Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology Am Soc Hematol Educ Program. 2012; 2012:506-511.","DOI":"10.1182\/asheducation.V2012.1.506.3798532"},{"key":"29099","doi-asserted-by":"crossref","unstructured":"Lorenz V, Ramsey H, Liu ZJ. Developmental stage-specific manifestations of absent TPO\/c-MPL signalling in newborn mice. Thromb Haemost. 2017; 117(12):2322-2333.","DOI":"10.1160\/TH17-06-0433"},{"key":"29100","doi-asserted-by":"crossref","unstructured":"Baker-Groberg SM, Lattimore S, Recht M, McCarty OJ, Haley KM. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost. 2016; 14(4):815-827.","DOI":"10.1111\/jth.13270"},{"key":"29101","doi-asserted-by":"crossref","unstructured":"Bunting S, Widmer R, Lipari T. Normal platelets and megakayocytes are produced in vivo in the absence of thrombopoietin. Blood. 1997; 90(9):3423-3429.","DOI":"10.1182\/blood.V90.9.3423"},{"key":"29102","doi-asserted-by":"crossref","unstructured":"Ballmaier M, Germeshausen M, Krukemeier S, Welte K.. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Ann N Y Acad Sci. 2003; 996:17-25.","DOI":"10.1111\/j.1749-6632.2003.tb03228.x"},{"key":"29103","doi-asserted-by":"crossref","unstructured":"Steinberg O, Gilad G, Dgany O. Congenital amegakaryocytic thrombocytopenia- 3 novel c-MPL mutations and their phenotypic correlations. J Pediatr Hematol Oncol. 2007; 29(12):822-825.","DOI":"10.1097\/MPH.0b013e318158152e"},{"key":"29104","doi-asserted-by":"crossref","unstructured":"Dame C, Wolber EM, Freitag P, Hofmann D, Bartmann P, Fandrey J.. Thrombopoietin gene expression in the developing human central nervous system. Brain Res Dev Brain Res. 2003; 143(2):217-223.","DOI":"10.1016\/S0165-3806(03)00134-2"},{"key":"29105","doi-asserted-by":"crossref","unstructured":"Ehrenreich H, Hasselblatt M, Knerlich F. A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A. 2005; 102(3):862-867.","DOI":"10.1073\/pnas.0406008102"},{"key":"29106","doi-asserted-by":"crossref","unstructured":"Ivanova A, Wuerfel J, Zhang J, Hoffmann O, Ballmaier M, Dame C.. Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system. BMC Dev Biol. 2010; 10:77.","DOI":"10.1186\/1471-213X-10-77"},{"key":"29107","doi-asserted-by":"crossref","unstructured":"Hoffmann O, Rung O, Im AR. Thrombopoietin Contributes to Neuronal Damage in Experimental Bacterial Meningitis. Infect Immun. 2011; 79(2):928-936.","DOI":"10.1128\/IAI.00782-10"},{"key":"29108","doi-asserted-by":"crossref","unstructured":"Castro Conde JR, Martinez ED, Rodriguez RC, Rodriguez De Hoyos AL. CNS siderosis and dandy-walker variant after neonatal alloimmune thrombocytopenia. Pediatr Neurol. 2005; 32(5):346-349.","DOI":"10.1016\/j.pediatrneurol.2004.11.008"},{"key":"29109","doi-asserted-by":"crossref","unstructured":"Goto T, Kakita H, Takasu M. A rare case of fetal extensive intracranial hemorrhage and whole-cerebral hypoplasia due to latent maternal vitamin K deficiency. J Neonatal Perinatal Med. 2018; 11(2):191-194.","DOI":"10.3233\/NPM-181745"},{"key":"29110","doi-asserted-by":"crossref","unstructured":"Marszal E, Jamroz E, Pilch J, Kluczewska E, Jablecka-Deja H, Krawczyk R.. Agenesis of corpus callosum: clinical description and etiology. J Child Neurol. 2000; 15(6):401-405.","DOI":"10.1177\/088307380001500609"},{"key":"29111","doi-asserted-by":"crossref","unstructured":"O'Keefe M, Kafil-Hussain N, Flitcroft I, Lanigan B.. Ocular significance of intraventricular haemorrhage in premature infants. Br J Ophthalmol. 2001; 85(3):357-359.","DOI":"10.1136\/bjo.85.3.357"},{"key":"29112","doi-asserted-by":"crossref","unstructured":"Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology. 2010; 117(3):615-622.","DOI":"10.1016\/j.ophtha.2009.08.023"},{"key":"29113","doi-asserted-by":"crossref","unstructured":"Y\u0131ld\u0131r\u0131m AT, G\u00fcnes BT, Oymak Y. Congenital amegakaryocytic thrombocytopenia: three case reports from patients with different clinical diagnoses and somatic abnormalities. Blood Coagul Fibrinolysis. 2015; 26(3):337-341.","DOI":"10.1097\/MBC.0000000000000192"},{"key":"29114","doi-asserted-by":"crossref","unstructured":"Zlotogora J. What is the birth defect risk associated with consanguineous marriages?. Am J Med Genet. 2002; 109(1):70-71.","DOI":"10.1002\/ajmg.10311"},{"key":"29115","doi-asserted-by":"crossref","unstructured":"Maserati E, Panarello C, Morerio C. Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica. 2008; 93(8):1271-1273.","DOI":"10.3324\/haematol.12748"},{"key":"29116","doi-asserted-by":"crossref","unstructured":"Matatall KA, Jeong M, Chen S. Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation. Cell Rep. 2016; 17(10):2584-2595.","DOI":"10.1016\/j.celrep.2016.11.031"},{"key":"29117","doi-asserted-by":"crossref","unstructured":"Walne AJ, Dokal A, Plagnol V. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica. 2012; 97(4):524-528.","DOI":"10.3324\/haematol.2011.052787"},{"key":"29118","doi-asserted-by":"crossref","unstructured":"Savoia A, Dufour C, Locatelli F. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Haematologica. 2007; 92(9):1186-1193.","DOI":"10.3324\/haematol.11425"},{"key":"29119","unstructured":"Kohler S, Carmody L, Vasilevsky N. Expansion of the human phenotype ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019; 47(D1):D1018-D1027."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9816\/71069","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9816\/71070","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9816\/71069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:57:39Z","timestamp":1794045459000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2020.257972","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}